76 related articles for article (PubMed ID: 2260040)
1. [When can the cases of toxic or adverse effects of drugs be rejected? 80 cases].
Lagier G; Castot A; Sabouraud S; de Cremoux P; Efthymiou ML
Therapie; 1990; 45(5):435-6. PubMed ID: 2260040
[No Abstract] [Full Text] [Related]
2. [Postmarketing surveillance of adverse reactions of drugs].
Polli EE; Cortellaro M
Ann Ital Med Int; 1989; 4(1):1-9. PubMed ID: 2702012
[No Abstract] [Full Text] [Related]
3. [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].
Bégaud B; Evreux JC; Jouglard J; Lagier G
Therapie; 1985; 40(2):111-8. PubMed ID: 4002188
[No Abstract] [Full Text] [Related]
4. [Mandatory report of adverse effects of drugs: has the order modified the spontaneous notification?].
Haramburu F; Pere JC; Begaud B; Albin H
Therapie; 1988; 43(6):493-6. PubMed ID: 3227516
[No Abstract] [Full Text] [Related]
5. [Methods for studying the adverse effects of drugs. I. Comparison of imputability methods: modelling and methodology].
Péré JC; Begaud B; Haramburu F; Albin H
Therapie; 1984; 39(3):279-89. PubMed ID: 6463953
[No Abstract] [Full Text] [Related]
6. Measuring adverse drug reactions in a postmarketing surveillance system.
Fisher S; Bryant SG; Kluge RM
Psychopharmacol Bull; 1986; 22(1):272-7. PubMed ID: 3726073
[No Abstract] [Full Text] [Related]
7. Pharmacovigilance in India: how safe are the new drugs? How sure are we?
Joshi SR; Sapatnekar SM
J Assoc Physicians India; 2008 Dec; 56():933-4. PubMed ID: 19322970
[No Abstract] [Full Text] [Related]
8. [Minimal information that should be found in reports about suspected adverse reactions of drugs].
Laporte JR; Lience E
Med Clin (Barc); 1991 Jun; 97(2):56-7. PubMed ID: 1895784
[No Abstract] [Full Text] [Related]
9. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
Pham E; Ventre JJ; Saddier P; Descotes J; Evreux JC
Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
[No Abstract] [Full Text] [Related]
10. Epidemiologic assessment of adverse drug effects.
Stern RS
Semin Dermatol; 1989 Sep; 8(3):136-40. PubMed ID: 2701270
[No Abstract] [Full Text] [Related]
11. Monitoring adverse drug reactions in the postmarketing phase.
Hoigné R; Hottinger S
Pharm Acta Helv; 1988; 63(1):2-12. PubMed ID: 3283774
[No Abstract] [Full Text] [Related]
12. Scientific challenges in postmarketing surveillance of ocular adverse drug reactions.
Fraunfelder FW; Fraunfelder FT
Am J Ophthalmol; 2007 Jan; 143(1):145-149. PubMed ID: 17188050
[TBL] [Abstract][Full Text] [Related]
13. Adverse drug reactions: a review of relevant factors.
Ajayi FO; Sun H; Perry J
J Clin Pharmacol; 2000 Oct; 40(10):1093-101. PubMed ID: 11028248
[TBL] [Abstract][Full Text] [Related]
14. [Information centers on undesirable effects of drugs: also on alerting function].
Bégaud B; Péré JC; Tubert P; Barat C; Haramburu F; Albin H
Therapie; 1987; 42(2):231-7. PubMed ID: 3617000
[No Abstract] [Full Text] [Related]
15. [Drug by drug imputation of adverse effects in drug monitoring. Attempted comparison of different methods].
Lagier G; Vincens M; Lefebure B; Frelon JH
Therapie; 1983; 38(3):295-302. PubMed ID: 6612666
[No Abstract] [Full Text] [Related]
16. An underrecognized challenge in evaluating postmarketing drug safety.
Roden DM
Circulation; 2005 Jan; 111(3):246-8. PubMed ID: 15668350
[No Abstract] [Full Text] [Related]
17. Adverse drug reactions.
Turner P
Hum Toxicol; 1986 May; 5(3):161-2. PubMed ID: 3710492
[No Abstract] [Full Text] [Related]
18. Nonlinear neural mapping analysis of the adverse effects of drugs.
Domine D; Guillon C; Devillers J; Lacroix R; Lacroix J; Doré JC
SAR QSAR Environ Res; 1998; 8(1-2):109-20. PubMed ID: 9517012
[TBL] [Abstract][Full Text] [Related]
19. Controversies in adverse drug reaction reporting.
Juergens JP
Am J Hosp Pharm; 1990 Jan; 47(1):76-7. PubMed ID: 2301428
[No Abstract] [Full Text] [Related]
20. The effect of backgrounds in safety analysis: the impact of comparison cases on what you see.
Gogolak VV
Pharmacoepidemiol Drug Saf; 2003; 12(3):249-52. PubMed ID: 12733479
[No Abstract] [Full Text] [Related]
[Next] [New Search]